Director's Report to the National Advisory Council on Drug Abuse
Extramural Policy and Review Activities
For this Council cycle, the Office of Extramural Affairs (OEA) arranged and managed 14 review meetings for grant applications including those in standing review committees, applications in conflict-of-interest with standing committees, and submissions to special initiatives. In addition, OEA arranged and managed fourteen contract proposal review meetings.
The reviews for NIDA's chartered committees were held. These consist of NIDA-E (Treatment Review Committee), NIDA-F (Health Services Review Committee), NIDA-L (Medications Development Committee), and NIDA-K (Training Committee). Five Special Emphasis Panels were held to review applications in conflict with the chartered committees. Three Special Emphasis panels were constituted for reviews of specific mechanisms: centers, program projects, and conference grant applications. In addition, OEA staff managed the reviews for B/START and Cutting Edge Basic Research Award (CEBRA) mechanisms.
The Contracts Review Branch managed the following proposal reviews:
||Purity Specifications, Storage and Distribution for Medication Development
||Develop Prevention Services Analytic Tools for Improved
Substance Abuse Prevention Delivery.
||Develop and Maintain Substance Abuse Prevention
||Prevention Training (Fast Track: Phase I and Phase II
||Virtual Reality for the Treatment of Pain (Fast Track)
||High-Throughput Screening of Functional Activity Proteins Using Biosensor-based Technology
||Analytical Techniques Program (Fast Track)
||Technologies for Localizing Gene Expression and Proteins in
the Nervous System
||Administrative and Meeting Support for the CTN
||Functional Imaging Agents
||Medicinal Chemistry-Design and Synthesis (Fast Track)
||Develop New Technologies for Drug Abuse Prevention
||Dosage Form Development
||Development of Science Education
Staff Training, Policy Development, and Extramural Activities
The OEA Symposium Series continued its monthly meetings for staff development, under the direction of Dr. Mark Swieter, SRA, Basic Sciences Review Branch. These sessions included a question and answer session with Dr. Glen Hanson, Acting Director, NIDA and Ms. Laura Rosenthal, Executive Officer and Associate Director, NIDA. Other sessions presented updates on and discussion of NIH extramural policies.
On March 1, 2002, Dr. Swieter gave a talk on the NIH Grants Enterprise to the NIDA INVEST and Humphrey fellows.
In anticipation of broader use of technology in peer review, Dr. Marina Volkov, SRA, Clinical, Epidemiological, and Applied Sciences Review Branch (CEASRB) and Ms. Marilyn Thomas, GTA, CEASRB, pilot tested a WEB based module for peer review for their February study section meeting.
Mr. Richard Harrison, Chief, Contracts Review Branch, has served as a reviewer for a number of minority-related initiatives, including: Administrative Supplement Applications for the NIDA Health Disparities Committee; Minority Supplement Applications for NIDA's Consortium on Minority Affairs, and Administrative Supplements for NIDA's Southern Africa Initiative.
Mr. Eric Zatman, Contracts Review Branch, continues to serve on the NIH committee revising the Contract manual "Initiation, Review, Evaluation and Award of Research & Development Contract Projects." This manual chapter guides policy for the review of contract proposals.
[Office of the Director][Report Index][Next Report Section]